bi-featured

Effects and Costs of Swine Respiratory Diseases

Porcine Respiratory Disease ComplexUnderstanding Porcine Respiratory Disease Complex Dr. Christa Goodell, Technical Manager, Boehringer Ingelheim Vetmedica, Inc., and Dr. Reid Philips, PRRS Senior Technical Manager, Boehringer Ingelheim, provides insight on the impact and costs of porcine respiratory diseases like Porcine Respiratory Disease Complex (PRDC), Porcine Reproductive And Respiratory Syndrome virus (PRRSv), and Influenza A Virus in Swine (IAV-S). Drs. Goodell and Philips outline approaches to diagnosis, treatment, and prevention within swine operations [video].

Boehringer Ingelheim Science In Practice Reception

Science In Practice ReceptionScience In Practice Reception Boehringer Ingelheim remembered Dr. Bob Morrison in their pre-Allen D. Leman Conference Science In Practice Reception. Additionally, Dr. Bob Thompson, PIC, received the the Science in Practice Award [video].

Comparison of Intestinal Lesions

Comparison of intestinal lesions between Enterisol® Ileitis and Porcilis® Ileitis using a Lawsonia intracellularis mucosal homogenate seeder pig challenge modelComparison of intestinal lesions between Enterisol® Ileitis and Porcilis® Ileitis using a Lawsonia intracellularis mucosal homogenate seeder pig challenge model Dr. Jessica Seate, Boehringer Ingelheim Vetmedica, Inc, presents research on a comparison of intestinal lesions between Enterisol® Ileitis and Porcilis® Ileitis using a Lawsonia intracellularis mucosal homogenate seeder pig challenge model. Dr. Seate concludes with a summary that shares that IHC scores and histologic lesions (H&E) were lower for Enterisol® Ileitis group compared to the Porcilis® Ileitis and NVC groups, Enterisol® Ileitis had lowest percentage of PCR positives at necropsy, and IgG Lawsonia ELISA titers are not indicative of protective immunity [video].

Efficacy of Ingelvac PRRS® MLV

Efficacy of Ingelvac PRRS® MLV against a heterologous PRRSV 1-7-4 RFLP challengeEfficacy of Ingelvac PRRS® MLV against a heterologous PRRSV 1-7-4 RFLP challenge Dr. Reid Philips, Boehringer Ingelheim Vetmedica, Inc, shares insights on the efficacy of Ingelvac PRRS® MLV against a heterologous PRRSV 1-7-4 RFLP challenge. Key findings include: Ingelvac PRRS® MLV demonstrated significant protection against a virulent PRRSv ‘174’ challenge: 1) Significant reduction in viremia, 2) Significant reduction in lung lesions, and 3) Significant improvement in Daily Gain. Also, Ingelvac PRRS® MLV continues to demonstrate cross protection against new-emerging field strains [video].

Comparison Of Efficacy Between Two Pcv2 Vaccination Protocols

Comparison of efficacy between two PCV2 vaccination protocols under PCV2d field exposureComparison of efficacy between two PCV2 vaccination protocols under PCV2d field exposure Dr. Eduardo Fano, Boehringer Ingelheim Vetmedica, Inc, shares a research comparison of efficacy between two PCV2 vaccination protocols under PCV2d field exposure. Key finding: No efficacy differences between these 2 vaccination protocols were documented in this study under 1) PCV2d field/natural challenge, and 2) PRRSV Co infection [video].

Learn More About The Infection/Prevention Chain

Introducing Infection/Prevention Chain™Introducing Infection/Prevention Chain™ Dr. Eduardo Fano, Tech Manager, Boehringer Ingelheim, shares and introduction to Infection/Prevention Chain™ to help swine operation staff and animal health professionals know about the approach. Dr. Fano says everything is connected and that mapping the processes will help teams know where the infection points exist. Take aways: The Infection/Prevention Chain concept is a tool for swine diseases management, using the whole herd approach, and it encourages systematic interventions [video].

What Is Whole Herd Swine Disease Control?

Whole herd approach to swine disease controlWhole herd approach to swine disease control Dr. Brian Payne, Regional Health Director, Pipestone System's Bethany (Illinois) and Rensselaer (Indiana) locations, brings to the audience the "in the field" practice of swine health and the focus points swine farms concentrate on. Dr. Payne talks about aiming to prevent the infections through the infection chain concept: if farm operations can minimize through preventing the infection chain then there is a better chance of not needing medication. [video].

Pig Performance and Care: What Are The Keys?

Keys to Positively Impact Pig Performance and CareMaking Impact Mark Schwartz, Schwartz Farms, provides insights on pig performance and care. Mr. Schwartz spends his day on looking at data to help improve on the performance of a pork operation. Key message: Continuously focus on creating and maintaining a production system to produce robust, healthy pigs [video].

Global Pork/Protein Update

Understanding the Course - Opportunities in a Global MarketUnderstanding the Course - Opportunities in a Global Market Brett Stuart, Global AgriTrends, shares a set of economic stories that impact the meat industry. Mr. Stuart believes the global economy is wobbly: governments pumping more money into the market, highlights the US currency vs others, Brazil issues, and EU pork prices. Take away is that China is lapping up EU supplies, US production is up (but domestic demand is uncertain), and market "gravity" is up on a long-term basis [video].

Global and European Pig Meat Market

Focus on Preparation - Anticipating Changing ConditionsFocus on Preparation - Anticipating Changing Conditions Dr. Miguel Angel Higuera, National Association of Swine Producers (Spain), shares global and European meat sector perspectives. Dr. Higuera points out that China, EU, then the US are the three biggest pork producers and consumers. On the flip side, the EU, USA, and Canada are the three biggest exporters of pork. Dr. Higuera dives into the EU market, consumer perceptions, and the how those perceptions have changed pork production in the EU. Dr. Higuera closes with a thought on how to get to 40 piglets per sow per year [video].
Syndicate content